K2 Principal Fund’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

K2 Principal Fund’s Portfolio CYNA Stock Details CYNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-286,023	Closed	-$11.5M	–	392
2016 Q3	$11.5M	Buy	+286,023	New	+$7.06M	1.29%	16

K2 Principal Fund's CYNA Position: Q4 2016 in Review

K2 Principal Fund sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 286,023 shares — an estimated $11.5M sold.

K2 Principal Fund first reported a position in CYNA in Q3 2016 and held it in 1 quarter. The position peaked at $11.5M in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

K2 Principal Fund reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
K2 Principal Fund sold 286,023 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $11.5M.
K2 Principal Fund first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q3 2016 and held it in 1 quarter.
K2 Principal Fund's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $11.5M in Q3 2016.
0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on K2 Principal Fund's 13F filing for Q4 2016, filed 15 Feb 2017.